Uncategorized
Insights Into Overcoming Drug Development Hurdles after Twenty Years of Drug Development Experience
By Dr. Zahra Shahrokh, chief development officer at STC Biologics, Inc. Overcoming Drug Development Hurdles It is gratifying when you evolve with the protein you have been “developing” and get it approved as a drug. As a young scientist the curiosity to “know” the protein in queue to development drove me to “play with it”,… Read More
Uncategorized
STC’s publication approved for B cell response in Tuberculosis
Last week STC Biologics, Inc. announced the approval of its publication on B cell response in adults with latent Tuberculosis in the Global Vaccine and Immunology Journal. These efforts were lead by Dr. Lisa Ganley-Leal, Director of Infectious Diseases, with the help of Dr. Thomas Schneider, Director of Biology, from STC Biologics Inc and also accredited to the on… Read More